Adult Dosing

Antiseptic, anesthetic

• Clean the affected area; spray a small amount on the affected area qd-tid prn

Note:

• May be covered with a sterile bandage; if bandaged, let dry first

Pediatric Dosing

Antiseptic, anesthetic

• Children >2 yrs
• Clean the affected area; spray a small amount on the affected area qd-tid prn

Note:

• May be covered with a sterile bandage; if bandaged, let dry first

[Outline]

• Adult Dosing
• Pediatric Dosing

• As an antiseptic for wound cleansing and as an anesthetic for temporarily relieving pain or discomfort in minor cuts, scrapes, and burns

• Hypersensitivity to any of the ingredients of the product

• N/A

Renal Dose Adjustment

• Renal impairment: Dose adjustments not defined

Hepatic Dose Adjustment

• Hepatic impairment: Dose adjustments not defined

See Supplemental Patient Information

• This combination drug is for external use only
• Consult a physician before use of therapy in case of deep or puncture wounds, animal bites, or serious burns
• Keep out of reach of children

Supplemental Patient Information

• Instruct patients to avoid using this drug in eyes or over large surface areas of the body
• Advise patients to discontinue use and consult a clinician if symptoms get worse or last more than 7 days or if the symptoms clear up and occur again within a few days
• On accidental swallowing of this drug, advise patients to immediately contact a Poison Control Center

Pregnancy Category:NR

Breastfeeding: Safety unknown. Topical maternal application of benzalkonium chloride or its presence as a preservative in pharmaceuticals is not expected to cause any adverse effects in breastfed infants. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 22 July 2011).

• HYPERSENSITIVITY: Anaphylactoid and hypersensitivity reactions
• DERM: Pruritus, urticaria, burning, contact dermatitis, edema, local irritation, stinging, tenderness, peeling, skin lesions

Benzalkonium chloride

• Anti-infective; exhibits marked antibacterial activity against a wide range of pathogenic bacteria, fungi, and viruses
• Metabolism: Unknown
• Excretion: Unknown
• Half-life: Unknown

Pramoxine

• Topical anesthetic; precise mechanism of action unknown; probably antagonizes histamine-mediated pruritus and inhibits initiation and conduction of nerve impulses to depress activity at the cutaneous sensory receptors
• Minimal systemic absorption
• Metabolism: Unknown
• Excretion: Unknown
• Half-life: Unknown

US Trade Name(s)

• Neosporin Neo to Go Spray

US Availability

Neosporin Neo to Go Spray (benzalkonium chloride/pramoxine)

• OTC SPRAY: 0.13%/1%

Canadian Trade Name(s)

• Polysporin Poly to Go

Canadian Availability

Polysporin Poly to Go (benzalkonium chloride/pramoxine)

• OTC SPRAY: 0.13%/1%

UK Trade Name(s)

• N/A

UK Availability

• N/A

Australian Trade Name(s)

• N/A

Australian Availability

• N/A

[Outline]

Antimicrobials

Antiseptics & Germicides

Infectious Disease

Antiseptics & Germicides

Dermatologic

Antiseptics & Germicides